These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

975 related items for PubMed ID: 18489579

  • 21. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J, Makkai B, Gulyás B, Hall H.
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [Abstract] [Full Text] [Related]

  • 22. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.
    Seeman P, McCormick PN, Kapur S.
    Synapse; 2007 May; 61(5):263-7. PubMed ID: 17318886
    [Abstract] [Full Text] [Related]

  • 23. The PDE10A inhibitor, papaverine, differentially activates ERK in male and female rat striatal slices.
    Hsu YT, Liao G, Bi X, Oka T, Tamura S, Baudry M.
    Neuropharmacology; 2011 Dec; 61(8):1275-81. PubMed ID: 21816164
    [Abstract] [Full Text] [Related]

  • 24. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT, Brooderson RJ, White FJ.
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [Abstract] [Full Text] [Related]

  • 25. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I, Rinne J, Marjamäki P.
    Pol J Pharmacol; 1999 Sep; 51(4):311-6. PubMed ID: 10540962
    [Abstract] [Full Text] [Related]

  • 26. Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
    Chong VZ, Skoblenick K, Morin F, Xu Y, Mishra RK.
    Neuroscience; 2006 Sep; 138(2):587-99. PubMed ID: 16413126
    [Abstract] [Full Text] [Related]

  • 27. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM, Bergman J.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [Abstract] [Full Text] [Related]

  • 28. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C, Abraini JH, David HN.
    Hippocampus; 2007 Dec; 17(11):1028-36. PubMed ID: 17604350
    [Abstract] [Full Text] [Related]

  • 29. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 30. The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.
    Chiang YC, Chen JC.
    J Neurochem; 2007 Dec; 103(6):2505-17. PubMed ID: 17953657
    [Abstract] [Full Text] [Related]

  • 31. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW, Zhang SP, Qin ZH, Weiss B.
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [Abstract] [Full Text] [Related]

  • 32. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW, Morford LL, Vorhees CV.
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [Abstract] [Full Text] [Related]

  • 33. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
    Seeman P, Tallerico T.
    Synapse; 2003 Mar 15; 47(4):250-4. PubMed ID: 12539197
    [Abstract] [Full Text] [Related]

  • 34. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D, Osborn CV.
    Eur J Pharmacol; 2005 Dec 28; 528(1-3):88-94. PubMed ID: 16324697
    [Abstract] [Full Text] [Related]

  • 35. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
    Wang HY, Undie AS, Friedman E.
    Mol Pharmacol; 1995 Dec 28; 48(6):988-94. PubMed ID: 8848015
    [Abstract] [Full Text] [Related]

  • 36. Negative feedback regulation of nigrostriatal dopamine release: mediation by striatal D1 receptors.
    Saklayen SS, Mabrouk OS, Pehek EA.
    J Pharmacol Exp Ther; 2004 Oct 28; 311(1):342-8. PubMed ID: 15175419
    [Abstract] [Full Text] [Related]

  • 37. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB, Duncker PC, Marshall JF.
    Synapse; 2011 Nov 28; 65(11):1144-55. PubMed ID: 21584865
    [Abstract] [Full Text] [Related]

  • 38. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
    St-Hilaire M, Landry E, Lévesque D, Rouillard C.
    Neurobiol Dis; 2005 Nov 28; 20(2):450-60. PubMed ID: 15896973
    [Abstract] [Full Text] [Related]

  • 39. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C, Abraini JH, David HN.
    Exp Neurol; 2008 Jul 28; 212(1):213-7. PubMed ID: 18501353
    [Abstract] [Full Text] [Related]

  • 40. DA D2 receptors in the ventral striatum: multiple effects or receptor subtypes?
    White FJ, Hu XT, Zhang XF.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr 28; 17(2):91-5. PubMed ID: 9201729
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.